← Eichor
Condition: Central Nervous System Leukemia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Central Nervous System Leukemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Orphan Indications for CD19 Redirected Autologous T Cells
Phase 2 · 1 location(s) · Stephan Grupp MD PhD · NCT04276870The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Phase 1/Phase 2 · 11 location(s) · AVM Biotechnology Inc · NCT04329728Children's Laughter and Fun Yoga as Adjunctive Pain Relief Following Chemotherapy.
NA · 1 location(s) · Bahaa Bou Dargham · NCT07327138Evaluation of Patients With HAM/TSP
Phase N/A · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT00001778Liquid Biopsy Evaluation and Repository Development at Princess Margaret
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT03702309Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT05011045Q702 for the Treatment of Patients With Hematologic Malignancies
Phase 1 · 2 location(s) · Mayo Clinic · NCT06712810SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Phase N/A · 68 location(s) · Massive Bio, Inc. · NCT034527743'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Phase N/A · 1 location(s) · Barbara Ann Karmanos Cancer Institute · NCT00935090A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Maligna
EARLY_Phase 1 · 1 location(s) · Zhejiang University · NCT04532203Long-term Follow-up Study of Patients Receiving CAR-T Cells
Phase N/A · 1 location(s) · Medical College of Wisconsin · NCT03375619European Prospective Investigation Into Childhood Cancer
Phase N/A · 1 location(s) · Columbia University · NCT05375617MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Phase 2 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT05735717Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT06213636Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Phase 2 · 1 location(s) · University of California, Irvine · NCT06580002CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
Phase 1/Phase 2 · 1 location(s) · Medical College of Wisconsin · NCT04186520Integrated Cancer Repository for Cancer Research
Phase N/A · 42 location(s) · University of Nebraska · NCT02012699Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy
NA · 1 location(s) · Children's Hospital Los Angeles · NCT06096272cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Phase N/A · 17 location(s) · Adela, Inc · NCT05366881The Efficacy of Therapy in Patients With Acute Myeloid Leukemia and Down Syndrome in Russia
Phase 3 · 1 location(s) · Federal Research Institute of Pediatric Hematology, Oncology · NCT07232134National Registry of Rare Kidney Diseases
Phase N/A · 1 location(s) · UK Kidney Association · NCT06065852Safety and Efficacy of SMART101 in Adult Patients With Hematological Malignancies After Haploidentical HSCT With Post-tr
Phase 1/Phase 2 · 4 location(s) · Smart Immune SAS · NCT05768035A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Phase 1 · 16 location(s) · Nurix Therapeutics, Inc. · NCT04830137Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute L
Phase 3 · 231 location(s) · Children's Oncology Group · NCT03959085Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection
Phase 2 · 1 location(s) · Carlos Brites · NCT07555431Phase Ib Clinical Study of Keynatinib
Phase 1 · 4 location(s) · Medolution Ltd. · NCT04807881A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Phase 1 · 62 location(s) · Nurix Therapeutics, Inc. · NCT05131022Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
NA · 347 location(s) · Eastern Cooperative Oncology Group · NCT05108298CAYA Cancer Prospective Cohort Study
Phase N/A · 3 location(s) · Resonance, Inc. · NCT07632014
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.